ETHZilla’s $250 million buyback highlights how companies are tapping crypto gains for liquidity — but analysts warn that leverage risks could turn treasuries into ticking time bombs. Ether treasury company ETHZilla, which recently pivoted from its biotechnology roots to cryptocurrency, has approved a $250 million share repurchase program — signaling that some firms may increasingly tap digital-asset gains as a source of liquidity.ETHZilla’s board of directors authorized the buyback of up to $250 million worth of its outstanding common shares, the company disclosed Monday. The company currently has 165.4 million shares outstanding.The move comes less than a month after the firm rebranded from 180 Life Sciences and made Ether (ETH) its core strategy — a pivot that helped revive its beaten-down stock. Read more ETHZilla’s $250 million buyback highlights how companies are tapping crypto gains for liquidity — but analysts warn that leverage risks could turn treasuries into ticking time bombs. Ether treasury company ETHZilla, which recently pivoted from its biotechnology roots to cryptocurrency, has approved a $250 million share repurchase program — signaling that some firms may increasingly tap digital-asset gains as a source of liquidity.ETHZilla’s board of directors authorized the buyback of up to $250 million worth of its outstanding common shares, the company disclosed Monday. The company currently has 165.4 million shares outstanding.The move comes less than a month after the firm rebranded from 180 Life Sciences and made Ether (ETH) its core strategy — a pivot that helped revive its beaten-down stock. Read more

After $400M splurge, ETH treasurer eyes stock buyback amid leverage concerns

2025/08/26 01:12
1 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

ETHZilla’s $250 million buyback highlights how companies are tapping crypto gains for liquidity — but analysts warn that leverage risks could turn treasuries into ticking time bombs.

Ether treasury company ETHZilla, which recently pivoted from its biotechnology roots to cryptocurrency, has approved a $250 million share repurchase program — signaling that some firms may increasingly tap digital-asset gains as a source of liquidity.

ETHZilla’s board of directors authorized the buyback of up to $250 million worth of its outstanding common shares, the company disclosed Monday. The company currently has 165.4 million shares outstanding.

The move comes less than a month after the firm rebranded from 180 Life Sciences and made Ether (ETH) its core strategy — a pivot that helped revive its beaten-down stock. 

Read more

Opportunità di mercato
Logo Moonveil
Valore Moonveil (MORE)
$0,00003785
$0,00003785$0,00003785
+0,23%
USD
Grafico dei prezzi in tempo reale di Moonveil (MORE)
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.

$30,000 in PRL + 15,000 USDT

$30,000 in PRL + 15,000 USDT$30,000 in PRL + 15,000 USDT

Deposit & trade PRL to boost your rewards!